Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.
Ahmad Al-SaffarHans LennernäsPer M HellströmPublished in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2019)
The risk of tardive dyskinesia due to metoclopramide is far below approximated numbers in treatment guidelines. This risk and the influence of known risk factors should be considered when starting a course of metoclopramide for treatment of gastroparesis.